Search Results - biologics

3 Results Sort By:
Specific Inhibitors of Reactive Oxygen Species (ROS) Production
UT Health San Antonio researchers have created recombinant mutant versions of NOXA1 and p67phox that inhibit generation of reactive oxygen species (ROS) by NOX enzymes. These polypeptides may be useful therapeutically as specific inhibitors of ROS overproduction to treat a variety of disease states.Background:ROS are important for a number of norm...
Published: 4/11/2013   |   Inventor(s): Anthony Valente, Robert Clark
Keywords(s): Biologics, Drugs
Category(s): Therapeutics > Biologics
Stent Deploment with Enhanced Delivery of Bio-Active Agents
Researchers at UT Health San Antonio have developed a stent for use in animals, including humans, which includes unprotected and protected regions, each protected regions including a bioactive or biopenetrating agent containing therein where the protected regions are protected by the unprotected regions when the stent is in its undeployed state whi...
Published: 3/4/2013   |   Inventor(s): Marc Feldman, Kyriacos Athanasiou, C. Mauli Agrawal, Steven Bailey
Keywords(s): Biologics, Medical Devices
Category(s): Medical Devices > Implants/Prostheses, Medical Devices > Surgical Equipment, Clinical Specialty > Cardiology
Endocrine Therapy Diagnostic for ER+ Breast Cancer
UT Health San Antonio seeks to partner with a diagnostic products company to develop and commercialize a clinical diagnostic with the potential to determine if a patient with estrogen receptor (ER) positive breast cancer is suitable for treatment with endocrine therapy (e.g., tamoxifen and/or the aromatase inhibitors anastrozole (Arimidex®), le...
Published: 2/7/2013   |   Inventor(s): Amy Trauernicht, Thomas Boyer
Keywords(s): Biologics, Drugs
Category(s): Diagnostics > Assay, Clinical Specialty > Oncology, Clinical Specialty > Women's Health